Quantification of the expression signal intensity in the different test groups reflected a significant increase in TNF-α and IL-17 in AP group compared to healthy control, whereas sitagliptin treatment resulted in significantly lower expression of both mediators compared to AP group that didn’t receive further treatments (Table 3, p < 0.05). Here, IL17A is linked to alkaline phosphatase measurement.